Le Lézard
Classified in: Health
Subject: ACC

Norgine France With 100 Years of Expertise Celebrates New Manufacturing Investment


AMSTERDAM, June 11, 2018 /PRNewswire/ --

Norgine B.V. a European specialist pharmaceutical company announced today the visit of Olivier Marleix, Member of the French Assemblée Nationale Eure-et-Loir, Wassim Kamel, Sub-Prefect of Dreux and Gérard Hamel, Mayor of Dreux to celebrate investment at its manufacturing site in Dreux, France.

     (Logo: http://mma.prnewswire.com/media/597589/Norgine_Logo.jpg )

Since 2015, the company has invested a total of EUR 8 million in its manufacturing and quality capabilities at the Dreux facility. This includes new technology to produce MOVICOL® Ready to Take and additional packaging facilities for LYMPHOSEEK® and DANTRIUM® IV.

Norgine employs over 1,000 personnel in Europe and Australia - with over 200 employees in France, located in Dreux and Rueil Malmaison:

Peter Stein, CEO at Norgine said: "Part of Norgine's strength as a partner lies in its high quality manufacturing and distribution facilities in Hengoed, Wales and Dreux, France. These help to enable Norgine to integrate and launch new innovative products which deliver value to healthcare professionals and improve patients' lives."

Access the full press release on http://www.norgine.com /media

Media Contact: 
Isabelle Jouin, T: +44-(0)-189-582-6237

Follow us @norgine 
https://www.linkedin.com/company/norgine/


These press releases may also interest you

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...

at 10:45
C?N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier...



News published on and distributed by: